SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060475
Filing Date
2023-11-08
Accepted
2023-11-07 17:54:38
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20230930.htm   iXBRL 10-Q 2584759
2 EX-10.6 nktr-ex10_6.htm EX-10.6 96512
3 EX-31.1 nktr-ex31_1.htm EX-31.1 15010
4 EX-31.2 nktr-ex31_2.htm EX-31.2 15277
5 EX-32.1 nktr-ex32_1.htm EX-32.1 10724
  Complete submission text file 0000950170-23-060475.txt   9122104

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20230930_pre.xml EX-101.PRE 290252
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20230930_cal.xml EX-101.CAL 52052
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20230930_def.xml EX-101.DEF 176342
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20230930.xsd EX-101.SCH 46317
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20230930_lab.xml EX-101.LAB 367721
55 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20230930_htm.xml XML 1866434
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 231385337
SIC: 2834 Pharmaceutical Preparations